PEP-Therapy et l’Institut Curie annoncent le traitement des premiers patients dans la phase Ib de l’essai clinique évaluant PEP-010 dans les cancers de l’ovaire et du pancréas
April 25, 2024 05:00 ET
|
PEP-Therapy
Communiqué de presse PEP-Therapy et l’Institut Curie annoncent le traitement des premiers patientsdans la phase Ib de l’essai clinique évaluant PEP-010dans les cancers de l’ovaire et du pancréas ...
PEP-Therapy and Institut Curie Announce First Patients Dosed in Phase Ib Clinical Trial Evaluating PEP-010 in Ovarian and Pancreatic Cancers
April 25, 2024 05:00 ET
|
PEP-Therapy
Press release PEP-Therapy and Institut Curie Announce First Patients Dosedin Phase Ib Clinical Trial Evaluating PEP-010in Ovarian and Pancreatic Cancers Paris (France), April 25, 2024 – PEP-Therapy,...
Peptide Therapeutics Analysis Report 2024 - Global Forecast to 2030 Featuring Eli Lilly and Co, Pfizer, Amgen, Takeda, AstraZeneca, Teva, Sanofi, F. Hoffmann-La Roche, Novartis, Novo Nordisk
April 22, 2024 04:14 ET
|
Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The...
Aanastra Inc to Present Multiple Posters on RNA Therapeutics at the American Association for Cancer Research (AACR) Annual Meeting 2024
April 03, 2024 06:30 ET
|
Aanastra Inc
Aanastra to present its RNA peptide therapeutics technology at AACR conference
Polaris Group Announced the Acquisition of Genovior Biotech, Initiating Dual-Engine Growth
December 21, 2023 21:16 ET
|
Polaris Group
TAIPEI, Taiwan and SAN DIEGO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Polaris Group (The Company, TWSE:6550) announced that its board approved to increase the acquisition of Genovior Biotech's shares to...
Peptide Therapeutics Market Set to Surpass USD 80 Billion by 2029: In-Depth Analysis of Global Trends and Clinical Trials
December 06, 2023 03:48 ET
|
Research and Markets
Dublin, Dec. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Peptide Therapeutics Market, Drug Dosage, Price & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's offering....
Global Biomaterials Market Soars to $102.8 Billion in 2022, Set to Surge to $202.7 Billion by 2028, Reveals New Report
October 24, 2023 07:43 ET
|
Research and Markets
Dublin, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The "Biomaterials Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Global Peptide Therapeutics Market 2023-2028: Advancements in Peptide Therapeutics Transform Medical Landscape with Targeted Treatments
August 30, 2023 07:23 ET
|
Research and Markets
Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Global Peptide Therapeutics Market (2023-2028) by Synthesis Technology, Drug Class, Route of Administration, API Type, Application, End User, and...
Global Human Microbiome Market Report to 2029: Rising Awareness About Importance of Human Microbiome Drives Growth
June 06, 2023 09:53 ET
|
Research and Markets
Dublin, June 06, 2023 (GLOBE NEWSWIRE) -- The "Global Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics), Application (Therapeutic, Diagnostics), Disease (Cancer, Gastrointestinal,...
Global Peptide Therapeutics Market Report 2023: Sector is Expected to Reach $69.3 Billion by 2030 at a CAGR of 6.6%
May 25, 2023 12:33 ET
|
Research and Markets
Dublin, May 25, 2023 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics Market, By Product Type, By Application, By Route of Administration, and By Region - Size, Share, Outlook, and Opportunity...